cjc-1295 with dac + ipamorelin No 10mg CJC-1295 Without DAC / Ipamorelin

Ipamorelin: The Pinnacle of Targeted Selectivity As science progressed, researchers identified the side effects of GHRP-6 and asked a vital question: Can we create a peptide that delivers the anti-aging benefits of growth hormone, without the appetite stimulation, cortisol spikes, and prolactin elevations

Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity

Materials such as polystyrene are usually used as a carrier to fix it in the reactor

Ipamorelin is often preferred when clinicians want GH support without the broader hormonal noise associated with some older secretagogues

Active ingredient identification was conducted for all samples, however only the results for the PCT samples are presented in this study